CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus

Activation of TLR7 and TLR9 by endogenous RNA- or DNA-containing ligands, respectively, can lead to hyper-activation of immune cells, including macrophages and DCs, subsequently contributes to the pathogenesis of SLE. CD180, a TLR-like protein, is specifically involved in the development and activat...

Full description

Bibliographic Details
Main Authors: Yonghong Yang, Cuiling Wang, Panpan Cheng, Xiaobei Zhang, Xuehui Li, Yuan Hu, Feihong Xu, Feng Hong, Guanjun Dong, Huabao Xiong
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2018.02643/full
_version_ 1818275927572873216
author Yonghong Yang
Yonghong Yang
Cuiling Wang
Panpan Cheng
Xiaobei Zhang
Xuehui Li
Yuan Hu
Feihong Xu
Feng Hong
Guanjun Dong
Huabao Xiong
author_facet Yonghong Yang
Yonghong Yang
Cuiling Wang
Panpan Cheng
Xiaobei Zhang
Xuehui Li
Yuan Hu
Feihong Xu
Feng Hong
Guanjun Dong
Huabao Xiong
author_sort Yonghong Yang
collection DOAJ
description Activation of TLR7 and TLR9 by endogenous RNA- or DNA-containing ligands, respectively, can lead to hyper-activation of immune cells, including macrophages and DCs, subsequently contributes to the pathogenesis of SLE. CD180, a TLR-like protein, is specifically involved in the development and activation of immune cells. Our previous study and others have reported that CD180-negative B cells are dramatically increased in SLE patients and responsible for the production of auto-antibodies. However, the mode of CD180 expression on macrophages and DCs in SLE remains unclear and the role of CD180 on regulating TLR7- and TLR9-mediated activation of macrophages and DCs are largely unknown. In the present study, we found that the percentages of CD180-negative macrophages and DCs were both increased in SLE patients and lupus-prone MRL/lpr mice compared with healthy donors and wild-type mice, respectively. Notably, ligation of CD180 significantly inhibited the activation of TLR7 and TLR9 signaling pathways in macrophages and DCs through the Lyn-SHP-1/2 axis. What's more, injection of anti-CD180 Ab could markedly ameliorate the lupus-symptoms of imiquimod-treated mice and lupus-prone MRL/lpr mice through inhibiting the activation of macrophages and DCs. Collectively, our results highlight a critical role of CD180 in regulating TLR7- and TLR9-mediated activation of macrophages and DCs, hinting that CD180 can be regarded as a potential therapeutic target for SLE treatment.
first_indexed 2024-12-12T22:37:32Z
format Article
id doaj.art-4398161509d4478a9c26f6c312cc6850
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-12T22:37:32Z
publishDate 2018-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-4398161509d4478a9c26f6c312cc68502022-12-22T00:09:25ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-11-01910.3389/fimmu.2018.02643420888CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine LupusYonghong Yang0Yonghong Yang1Cuiling Wang2Panpan Cheng3Xiaobei Zhang4Xuehui Li5Yuan Hu6Feihong Xu7Feng Hong8Guanjun Dong9Huabao Xiong10Institute of Immunology and Molecular Medicine, Jining Medical University, Jining, ChinaDepartment of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Hematology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Hematology, Affiliated Hospital of Jining Medical University, Jining, ChinaDepartment of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, ChinaInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, ChinaDepartment of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesDepartment of Central Laboratory, Affiliated Hospital of Jining Medical University, Jining, ChinaInstitute of Immunology and Molecular Medicine, Jining Medical University, Jining, ChinaDepartment of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United StatesActivation of TLR7 and TLR9 by endogenous RNA- or DNA-containing ligands, respectively, can lead to hyper-activation of immune cells, including macrophages and DCs, subsequently contributes to the pathogenesis of SLE. CD180, a TLR-like protein, is specifically involved in the development and activation of immune cells. Our previous study and others have reported that CD180-negative B cells are dramatically increased in SLE patients and responsible for the production of auto-antibodies. However, the mode of CD180 expression on macrophages and DCs in SLE remains unclear and the role of CD180 on regulating TLR7- and TLR9-mediated activation of macrophages and DCs are largely unknown. In the present study, we found that the percentages of CD180-negative macrophages and DCs were both increased in SLE patients and lupus-prone MRL/lpr mice compared with healthy donors and wild-type mice, respectively. Notably, ligation of CD180 significantly inhibited the activation of TLR7 and TLR9 signaling pathways in macrophages and DCs through the Lyn-SHP-1/2 axis. What's more, injection of anti-CD180 Ab could markedly ameliorate the lupus-symptoms of imiquimod-treated mice and lupus-prone MRL/lpr mice through inhibiting the activation of macrophages and DCs. Collectively, our results highlight a critical role of CD180 in regulating TLR7- and TLR9-mediated activation of macrophages and DCs, hinting that CD180 can be regarded as a potential therapeutic target for SLE treatment.https://www.frontiersin.org/article/10.3389/fimmu.2018.02643/fullCD180TLRSLEmacrophageDCs
spellingShingle Yonghong Yang
Yonghong Yang
Cuiling Wang
Panpan Cheng
Xiaobei Zhang
Xuehui Li
Yuan Hu
Feihong Xu
Feng Hong
Guanjun Dong
Huabao Xiong
CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
Frontiers in Immunology
CD180
TLR
SLE
macrophage
DCs
title CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
title_full CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
title_fullStr CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
title_full_unstemmed CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
title_short CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus
title_sort cd180 ligation inhibits tlr7 and tlr9 mediated activation of macrophages and dendritic cells through the lyn shp 1 2 axis in murine lupus
topic CD180
TLR
SLE
macrophage
DCs
url https://www.frontiersin.org/article/10.3389/fimmu.2018.02643/full
work_keys_str_mv AT yonghongyang cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT yonghongyang cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT cuilingwang cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT panpancheng cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT xiaobeizhang cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT xuehuili cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT yuanhu cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT feihongxu cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT fenghong cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT guanjundong cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus
AT huabaoxiong cd180ligationinhibitstlr7andtlr9mediatedactivationofmacrophagesanddendriticcellsthroughthelynshp12axisinmurinelupus